NASDAQ$IXHL
Incannex Healthcare Inc · Q1 2026 earnings
Q1 2026 earnings · · Before market open
Briefing
Incannex Healthcare reported Q1 2026, net loss of $6.4M.
For Q1 2026, Incannex Healthcare reported a net loss of $6.4M. Management discusses operations, liquidity, and outlook in the quarterly filing.
- Net loss $6.4M.
- Incannex Healthcare MD&A covers cash runway, pipeline, and sector risks.
- Incannex Healthcare MD&A covers cash runway, pipeline, and sector risks.
Headline financials
Revenue & EPS history
Incannex Healthcare Inc · Revenue · Quarterly
-$0.02
Forward guidance
The quarterly filing discusses operating priorities, liquidity, and sector-specific risks.
Tailwinds
- MD&A highlights business model and cash trends.
- Management commentary on near-term priorities.
Headwinds
- Macro, rates, or input costs may pressure results.
- One-time items affect YoY comparability.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 5 quarterly earnings reports · overlaid with Q1 2026
-0.9%
Avg return
Earnings day
-3.8%
Avg return
5 days after
-12.2%
Avg return
30 days after
33%
2 / 6 earnings
Positive
+11.8%
Q2 2024
Best reaction
-11.7%
Q1 2025
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q3 2026 | +1.8% | -5.1% | -1.8% | |
| Q1 2026 | -1.4% | -6.7% | +18.5% | |
| Q2 2025 | -0.9% | -9.8% | -58.8% | |
| Q1 2025 | -11.7% | -18.9% | -29.8% | |
| Q3 2024 | -5.2% | -16.5% | +8.5% | |
| Q2 2024 | +11.8% | +34.4% | -9.8% |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro